Add interventional psychiatry by accessing TMS equipment, purpose-built rooms for dosing, trained monitoring staff, and opportunities to collaborate with on-site therapists.
The problem
Writing the script is the easy part
Getting your patients the interventional treatment you prescribed them is the hard part. Delivering TMS requires equipment and technicians, and Spravato and future psychedelic therapies require an FDA-enrolled site, direct observation through the session, continuous monitoring, and detailed record keeping for DEA and FDA.
I’ve always wanted to offer interventional treatments, but the infrastructure has seemed too daunting. Clearlight gives me that opportunity!
Incorporate these new interventional treatments
Expand the care you can offer with purpose-built space, clinical support, and colleagues in one place. Clearlight is planning for established interventions and the next generation of treatment.
Spravato® (esketamine)
Established treatment
Offer supervised esketamine treatment for eligible adults, with dedicated session space, on-site observation, and monitoring in a certified healthcare setting.
Transcranial magnetic stimulation (TMS)
Established treatment
Add noninvasive brain stimulation to your practice with treatment equipment, dedicated space, and trained operational support for a scheduled course of care.
Future psychedelic-assisted therapy
Future offering · Subject to approval
Prepare to offer psychedelic medicines if approved, combining supervised treatment and monitoring with preparation and integration alongside trained therapists. Workflows will follow final product requirements and clinician privileges.
The benefits of practicing here
Space
Rooms built around supervised dosing
Not exam rooms with the chairs moved. Quiet, comfortable spaces designed for sessions that run for hours, with the layout, monitoring lines and discharge flow the protocols assume.
Staffing
Nursing and monitoring cover for every session
Trained staff are on site for observation, vital-sign monitoring, and stable-discharge checks.
Collaboration
Coordinate care with on-site therapists
Connect with on-site therapists to coordinate care for your patients, when clinically appropriate and consistent with patient choice. Shared space supports communication and collaboration throughout treatment.
Operations
REMS requirements, handled
Like Spravato, new psychedelic medicines are expected to fall under a REMS, which requires certified prescribers and sites and set procedures before, during and after each dose. Clearlight can help you with session-level records, patient enrollment, and adverse-event reporting that come with it.
Join a Clearlight-contracted medical group to practice
Apply to practice at Clearlight. If you are a fit, we will get you credentialed and enrolled in health plans so you can bring your cases onsite and follow your patients through their treatment. Clearlight will take care of this process so you can focus on your patients.
Why the setting matters
A Risk Evaluation and Mitigation Strategy governs the system that delivers an approved medicine, not only the medicine itself. It restricts dispensing to enrolled healthcare settings, ties the certified prescriber to the certified location, and sets what has to happen before, during and after a dose.